CatalystPit

EWTXEdgewise Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $40.60 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$4.41B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-02 · Fox Jonathan C (Director) · OTHER
  • 2026-08-14 · Donovan Joanne M. (CMO) · SELL
  • 2026-08-14 · MOORE JOHN R (General Counsel) · OTHER
  • 2026-08-14 · Russell Alan J (Chief Scientific Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders244
Shares held137,761,262
Value$5.23B
Percent of shares outstanding126.85%
As of quarter end2026-06-30
RECENT NEWS
  • Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
  • Edgewise Therapeutics reports inducement stock grants
  • Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 Transcript
  • Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 - Slideshow
  • Edgewise Therapeutics unveils mechanism of action for cardiac sarcomere modulator EDG-7500
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Edgewise Therapeutics, Inc. (EWTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit